Tachycardia Detection Algorithm Using Dual-Vector EGM Sensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter defibrillators face challenges in accurately distinguishing between supraventricular tachycardia (SVT) and ventricular tachycardia (VT), leading to inappropriate therapy delivery and potential battery inefficiency due to the similarity in tachycardia cycle lengths and retrograde conduction patterns.
Innovation Solution
A tachycardia detection algorithm utilizing dual-vector EGM sensing to estimate heart rates and apply beat-by-beat rules for discriminating between VT and SVT, employing RR interval analysis, morphology scoring, and specific beat feature extraction to accurately classify rhythms and guide appropriate therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If tachycardia detection uses standard single-vector sensing, then device complexity is low, but measurement precision of rhythm classification deteriorates due to inability to distinguish SVT from VT
Solution Approach 1:
The patent divides the sensing system into multiple independent sensing vectors (first sensing vector and second sensing vector) that simultaneously monitor cardiac electrical activity from different orientations. This segmentation allows the device to compare morphological features across vectors, significantly improving rhythm classification accuracy between SVT and VT while maintaining manageable device complexity through modular architecture.
Solution Approach 2:
The patent transitions from single-vector (one-dimensional) sensing to multi-vector (multi-dimensional) sensing by adding spatial dimensionality to the electrical signal acquisition. By sensing cardiac activity along multiple vectors simultaneously, the system creates a more comprehensive electrical map of cardiac activity, enabling superior discrimination between SVT and VT rhythms through morphological comparison across dimensional axes.
2Reliability
If high-voltage cardioversion shocks are delivered to terminate tachycardia, then therapy effectiveness is high, but energy consumption increases and patient comfort deteriorates
Solution Approach 1:
The patent implements preliminary rhythm classification using multi-vector sensing and morphology analysis before initiating therapy delivery. By accurately identifying whether the tachycardia is SVT or VT in advance, the system can select the most appropriate therapy modality (pacing vs. shock), potentially terminating treatable rhythms with less aggressive pacing therapies before resorting to high-energy cardioversion shocks, thereby conserving battery charge.
Solution Approach 2:
The system continuously monitors cardiac electrical activity using multiple sensing vectors and provides real-time feedback on rhythm classification. This feedback mechanism allows dynamic adjustment of therapy selection based on ongoing analysis of electrical morphology, enabling the device to confirm successful termination of tachycardia and avoid unnecessary high-energy shocks by detecting return to normal rhythm through the same multi-vector feedback system.
3Reliability
If aggressive cardioversion therapy is used as default treatment, then reliability of tachycardia termination is high, but loss of time for accurate diagnosis increases
Solution Approach 1:
The patent performs preliminary rhythm classification using multi-vector morphology analysis immediately upon detecting tachycardia, before initiating any therapy. This preliminary action rapidly identifies whether the rhythm is SVT or VT based on electrical morphology characteristics, enabling immediate selection of the most appropriate therapy modality without delay, thus eliminating the need for time-consuming sequential diagnosis while maintaining high termination reliability.
Solution Approach 2:
The system changes the diagnostic parameter from simple rate detection to multi-vector morphology analysis, which provides richer information for rapid rhythm classification. By analyzing electrical signal characteristics across multiple vectors simultaneously, the system achieves accurate SVT/VT differentiation in real-time, enabling fast therapy selection without sacrificing diagnostic accuracy or termination reliability.
Data Source
AI summary
A medical device and associated method for discriminating cardiac events sense cardiac signals that includes determining whether a first match score is within one of a first match zone corresponding to a first cardiac event, and a second match zone corresponding to the first cardiac event, and determining whether a second match score is within one of the first match zone, the second match zone, and a third match zone corresponding to a second cardiac event different from the first cardiac event. One of increasing and decreasing an event counter is performed in response to both the determination of whether the first match score is within one of the first match zone and the second match zone and the determination of whether the second match score is within one of the first match zone, the second match zone, and the third match zone.